Phase 1 Carcinoma, Squamous Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

Head and Neck NeoplasmsNeoplasm MetastasisCarcinoma, Squamous Cell+3 more

University of Chicago36 enrolled1 locationNCT06912087

Recruiting

Phase 1

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

Carcinoma, Squamous Cell

Melissa Pugliano-Mauro30 enrolled1 locationNCT03370406